Inactive Instrument

Insiders MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Real-time Estimate Tradegate Other stock markets 08:29:34 2024-05-31 EDT			5-day change	1st Jan Change
67.9 ^EUR	0.00%		0.00%	0.00%

05-20	European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	MT
05-17	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	01-16	MT
Higher Oil Prices, Interest Rate Worries Weigh on Exchange-Traded Funds, Equity Futures Premarket Wednesday	23-09-13	MT
MorphoSys Appoints Lucinda Crabtree as CFO	23-03-14	MT
Morphosys Ag Appoints Lucinda Crabtree as CFO	23-03-14	CI
Morphosys Ag Appoints Lucinda Crabtree as Member of the Management Board	23-03-14	CI
Vir Biotechnology Names New Chief Financial Officer; Shares Down	23-02-16	MT
MorphoSys CFO to Quit in March 2023	22-12-20	MT
MorphoSys AG Announces Sung Lee, Management Board Member, Decided to Leave	22-12-20	CI
German pharma company MorphoSys's finance head to step down	22-12-20	RE
MorphoSys AG Announces Executive Changes	22-08-31	CI
MorphoSys AG Announces Supervisory Board Changes	22-05-18	CI
MorphoSys Announces Departure of Roland Wandeler as Chief Operating Officer, Effective December 31, 2021	21-11-09	CI
MorphoSys Ag Announces Executive Changes	21-07-29	CI
BioNTech : Former MorphoSys Executive Joins BioNTech as CFO	21-05-18	MT
MorphoSys : Hires Sung Lee as CFO	21-01-06	MT
MorphoSys Appoints Thomas Biegi as Vice President, Head of Corporate Communications	20-12-01	CI
Jens Holstein Decides to Step Down as Member of the Morphosys AG's Management Board, Effective December 31, 2020	20-09-30	CI
MorphoSys AG Announces Resignation of Frank Morich from the Supervisory Board	20-05-28	CI
MorphoSys AG Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer, Effective May 5, 2020	20-04-21	CI
MorphoSys : Chief scientist quits at Germany's Morphosys ahead of product launch	19-11-21	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Insiders

Filters